Evidence map›Paper›PMID 29863124›Full record

ReviewAnnals of gastroenterological surgery2018

Occupational cholangiocarcinoma caused by exposure to 1,2-dichloropropane and/or dichloromethane.

Shoji Kubo, Shigekazu Takemura, Shogo Tanaka, Hiroji Shinkawa, Masahiko Kinoshita, Genya Hamano, Tokuji Ito, Masaki Koda, Takanori Aota

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Annals of gastroenterological surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07337850 (FAP 2), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07337850 recruitingnot on this mapstarted 2024, after this paper: background citation

FAP 2: Utility of Gallium-68-Fibroblast Activation Protein Inhibitor (FAPI) PET in Biliary Tract Cancers: A Prospective Study

TypeobservationalSponsorTata Memorial CentreRan2024 to 2026Enrolled60ConditionsGall Bladder Cancer, Intrahepatic Cholangiocarcinoma (Icc)Armsgallium-68-Fibroblast Activation Protein Inhibitor
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Cholangiocarcinoma Attributed to Occupation: A Systematic Reviews.Asian Pacific journal of cancer prevention : APJCP · 2022
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Surgical management of biliary malignancy.Current problems in surgery · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shoji KuboDepartment of Hepato-Biliary-Pancreatic Surgery Osaka City University Graduate School of Medicine Osaka Japan.ORCID 0000-0002-4353-8033
Shigekazu TakemuraDepartment of Hepato-Biliary-Pancreatic Surgery Osaka City University Graduate School of Medicine Osaka Japan.
Shogo TanakaDepartment of Hepato-Biliary-Pancreatic Surgery Osaka City University Graduate School of Medicine Osaka Japan.
Hiroji ShinkawaDepartment of Hepato-Biliary-Pancreatic Surgery Osaka City University Graduate School of Medicine Osaka Japan.
Masahiko KinoshitaDepartment of Hepato-Biliary-Pancreatic Surgery Osaka City University Graduate School of Medicine Osaka Japan.
Genya HamanoDepartment of Hepato-Biliary-Pancreatic Surgery Osaka City University Graduate School of Medicine Osaka Japan.
Tokuji ItoDepartment of Hepato-Biliary-Pancreatic Surgery Osaka City University Graduate School of Medicine Osaka Japan.
Masaki KodaDepartment of Hepato-Biliary-Pancreatic Surgery Osaka City University Graduate School of Medicine Osaka Japan.
Takanori AotaDepartment of Hepato-Biliary-Pancreatic Surgery Osaka City University Graduate School of Medicine Osaka Japan.
Osaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A cluster of cholangiocarcinoma among printing company workers who were exposed to 1,2-dichloropropane and/or dichloromethane was classified by the Ministry of Health, Labour and Welfare of Japan on 1 October 2013 as "occupational cholangiocarcinoma". At the time of the diagnosis of cholangiocarcinoma, levels of γ-glutamyl transferase, and aspartate and alanine aminotransferases were elevated, and had been elevated in some patients several years prior to the diagnosis. Regional dilatation of intrahepatic bile ducts without tumor-induced obstruction was characteristic in diagnostic imaging. Pathological examination found chronic bile duct injury with DNA damage, precancerous/preinvasive lesions such as biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct in various sites of the large bile ducts, and invasive cholangiocarcinoma such as mass-forming type and intraductal growth-type intrahepatic cholangiocarcinoma and mainly papillary-type extrahepatic cholangiocarcinoma. Whole-exome analysis of the cancerous tissues showed hypermutation, substantial strand bias, and unique trinucleotide mutational changes. Patients seemed to suffer high incidence of postoperative complications including intra-abdominal, which might be related to chronic bile duct injury. Postoperative recurrence from multicentric origins occurred in some patients, as DNA-injured bile ducts have high carcinogenic potential. Aggressive treatment, including second resections for such multicentric recurrences, appeared to be effective. In 2014, the International Agency for Research on Cancer classified 1,2-dichloropropane as Group 1 (carcinogenic to humans) and dichloromethane as Group 2A (probably carcinogenic to humans) carcinogens.

Indexed as

1,2‐dichloropropanebiliary intraepithelial neoplasiacholangiocarcinomadichloromethaneintraductal papillary neoplasm of the bile duct

Identifiers

PMID29863124
PMCPMC5881298
OpenAlexW2769890434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.